NDC 42291-962-11 - Yuvafem
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 42291-962
- Requested NDC
- 42291-962-11
- Package NDCs from labels
- 42291-962-11, 42291-962-08, 42291-962-18
- Manufacturer
- AvKARE
- Effective date
- 2026-01-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Yuvafem - AvKARE | AvKARE | 2026-01-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 42291-962-08 | Yuvafem | 8 in 1 CARTON | TABLET | 8 | 9 | |
| 42291-962-11 | Yuvafem | 1 in 1 APPLICATOR | TABLET | 1 | 9 | |
| 42291-962-18 | Yuvafem | 18 in 1 CARTON | TABLET | 18 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 42291-962-08 | EA - Each | 42291-962 | 1e865e1b-5df2-422c-bcdf-4889a01d7a00 | 1 | 2016-12-07 |
| 42291-962-11 | EA - Each | 42291-962 | b6e839c4-ff41-493e-b670-a91f756e23f6 | 1 | 2025-05-14 |
| 42291-962-18 | EA - Each | 42291-962 | cd5dff2b-a8de-4bdb-8f73-395b7066d495 | 1 | 2016-12-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Estradiol | ESTRADIOL | REMEDYREPACK INC. | 59a4b68d-a507-4809-a0c8-fd9799986d12 | 2026-06-10 | Boxed warning, Warnings, Adverse reactions | 4TI98Z838E |
| Estradiol | ESTRADIOL | A-S Medication Solutions | ba935918-39b3-4b56-bd83-78a29958e6d8 | 2026-06-10 | Boxed warning, Warnings, Adverse reactions | 4TI98Z838E |
| Estradiol | ESTRADIOL | A-S Medication Solutions | 1c38f0d0-a360-4b66-bc0e-7d54e92465a1 | 2026-06-10 | Boxed warning, Warnings, Adverse reactions | 4TI98Z838E |
| ESTRADIOL | ESTRADIOL | REMEDYREPACK INC. | 477cb52e-8ce2-491f-94a0-869ff60bf7ab | 2026-06-08 | Boxed warning, Warnings, Adverse reactions | 4TI98Z838E |
| Rohto Digi-Eye | HYPROMELLOSE, TETRAHYDROZOLINE HYDROCHLORIDE | The Mentholatum Company | 5d6f37b9-b568-4cb6-92de-eb40779f3f8c | 2026-06-03 | Warnings | 3NXW29V3WO |
| Estradiol | ESTRADIOL | A-S Medication Solutions | eacafc4a-2fa8-403d-8df7-2bc92d73a54f | 2026-06-03 | Boxed warning, Warnings, Adverse reactions | 4TI98Z838E |
| Estradiol | ESTRADIOL | A-S Medication Solutions | ee5460ab-27e7-487a-a89c-bf8735399be6 | 2026-06-03 | Boxed warning, Warnings, Adverse reactions | 4TI98Z838E |
| Estradiol | ESTRADIOL | REMEDYREPACK INC. | 774ee81b-8e29-46af-ab12-7157f63b443b | 2026-06-01 | Boxed warning, Warnings, Adverse reactions | 4TI98Z838E |
| EstroGel | ESTRADIOL | ASCEND Therapeutics US, LLC | 762ac371-bb8b-47e7-b48f-e80d452c9dd4 | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | 4TI98Z838E |
| Estradiol and Norethindrone Acetate | ESTRADIOL AND NORETHINDRONE ACETATE | Ingenus Pharmaceuticals, LLC | 50c786d6-91bd-4eea-9455-ff2abc08372f | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | 4TI98Z838E |
| ESTRADIOL | ESTRADIOL | A-S Medication Solutions | afd70875-0a93-40a7-842e-f4359818c2d9 | 2026-05-27 | Boxed warning, Warnings, Adverse reactions | 4TI98Z838E |
| Estradiol | ESTRADIOL GEL 0.1% | Xiromed, LLC | 1a46efe6-21b9-3f0f-90b9-59f279ef51df | 2026-05-18 | Boxed warning, Warnings, Adverse reactions | 4TI98Z838E |
| ESTRADIOL | ESTRADIOL | Encube Ethicals, Inc. | 54f108d6-ddd2-4276-8508-2c8e16a65fb2 | 2026-05-13 | Boxed warning, Warnings, Adverse reactions | 4TI98Z838E |
| Estradiol Gel | ESTRADIOL | Encube Ethicals, Inc. | d4a3606f-83b2-45df-bc77-faebfa796f9a | 2026-04-29 | Boxed warning, Warnings, Adverse reactions | 4TI98Z838E |
| Estring | ESTRADIOL | Pfizer Laboratories Div Pfizer Inc | 110b9865-5a07-4d45-b560-e89947f12600 | 2026-04-23 | Warnings, Adverse reactions | 4TI98Z838E |
| Caldesene Baby | STARCH, CORN AND ZINC OXIDE | Insight Pharmaceuticals LLC | 9f12dee2-7afa-45e9-a729-0fd42bb77715 | 2026-04-22 | Warnings | O8232NY3SJ |
| Caldesene Medicated Protecting | CORNSTARCH AND ZINC OXIDE | Insight Pharmaceuticals LLC | ffc92a0f-a7cf-4a46-b2f1-089df2bbb96b | 2026-04-22 | Warnings | O8232NY3SJ |
| Estradiol Vaginal | ESTRADIOL | A-S Medication Solutions | 0137d491-6917-4060-9b32-e0cd7b0badbb | 2026-04-13 | Boxed warning, Warnings, Adverse reactions | 4TI98Z838E |
| Estradiol | ESTRADIOL | Preferred Pharmaceuticals, Inc. | 6d129a94-8ecd-40a3-9a95-c5e1ece41ab1 | 2026-04-13 | Boxed warning, Warnings, Adverse reactions | 4TI98Z838E |
| Exovisse Preservative-Free Artificial Tears | LUBRICANT EYE GEL DROPS | YD BIO USA, INC. | 4f20191a-9124-2525-e063-6294a90a8428 | 2026-04-10 | Warnings | 3NXW29V3WO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.